摘要
摘要目的分析临床支原体、支原体宫颈炎患者行干扰素、阿奇霉素联合疗法的效果.方法调查对象从我院２０１２年３月－２０１４年７月所接收患者中抽选,分成不同临床疗法组,即对照组支原体、衣原体宫颈炎患者行干扰素疗法,研究组患者行干扰素＋阿奇霉素疗法,于临床预后评估疾病效果.结果研究组患者临床疾病结果９５．０％高于对照组７５．０％,不良反应发生率５．０％低于对照组２０．０％,存在差异(P＜０．０５).结论临床支原体、衣原体宫颈炎患者治疗期间行干扰素＋阿奇霉素联合疗法作用显著,可改善患者生活现状,不良反应轻微,值得借鉴.关键词干扰素;阿奇霉素;支原体;衣原体宫颈炎Abstractobjectivetoanalyzeclinicalmycoplasmaandmycoplasmacervicitispatientswithinterferon,theeffectofazithromycincombinationtherapy．MethodsasurveyfromourhospitalinMarch２０１２－July２０１４receivedselectedamongpatients,clinicaltherapyweredividedintodifferentgroups,namelythecontrolgroupmycoplasma,chlamydiacervicitispatientsinterferontherapy,patientsgroupofinterferonplusazithromycintherapy,fromclinicalprognosticevaluＧationeffect．Resultsthegrouppatientsclinicaldiseaseresults９５．０％higherthanthatofcontrolgroup７５．０％,５．０％lowerthanthecontrolgroup５．０％incidenceofadversereactions,therearedifferences(P＜０．０５)．Conclusionclinicalmycoplasma,chlamydia,cervicitispatientsduringtreatmentlineofinterferonplusazＧithromKyecyinwcoordmsbinationtherapyeffect,canimprovethepatientslife,littleadversereaction,whichisworthusingforreference．Interferon;Azithromycin;Mycoplasma;Chlamydiacervicitis中图分类号R４文献标识码B文章编号１００１－５３０２(２０１５)０９－０６５７－０２
出版日期
2015年09月19日（中国期刊网平台首次上网日期，不代表论文的发表时间）
